230 research outputs found
Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives
The clinical goals of risk stratification of sudden death are to identify subjects who are at high
risk of, and eventually to reduce the incidence of, sudden death. Numerous studies have
described risk stratification techniques for serious cardiac events in patients following myocardial
infarction. However, relatively little information is available regarding nonischemic dilated
cardiomyopathy. A number of diagnostic methods have been used for risk stratification of
patients with nonischemic dilated cardiomyopathy, including presence of syncope, ambulatory
electrocardiographic monitoring, programmed ventricular stimulation, QRS duration, QT
interval dispersion, QT interval dynamicity, signal-averaged ECG, heart rate variability,
heart rate turbulence, baroreflex sensitivity, heart rate recovery, exercise recovery ventricular
ectopy, fragmented QRS and cardiac magnetic resonance imaging. In this review, existing
data regarding risk stratification of sudden cardiac death in nonischemic dilated cardiomyopathy
will be summarized and its implications in clinical practice will be reviewed. (Cardiol J
2010; 17, 3: 219-229
Emergency polytetrafluoroethylene-covered stent implantation to treat right coronary artery perforation during percutaneous coronary intervention
Coronary artery perforations are life-threatening complications with a poor outcome. Historically,
if the perforation was not controlled using conservative methods such as prolonged
balloon inflation and protamine administration, emergency cardiac surgery has been performed.
However, several percutaneous methods including covered stents and embolization
materials have emerged as therapeutic options to manage coronary perforations. We report
a case of right coronary artery perforation after high pressure stent post-dilatation that was
successfully sealed with a polytetrafluoroethylene-covered stent
Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time
Background: The main purpose of this study is to determine the correlation of inter- and
intraatrial conduction times between the electrophysiological and tissue Doppler
echocardiographic measurements, and to evaluate the appropriateness of tissue Doppler
echocardiography for this measurement.
Methods: One-hundred and one patients were included in the study who underwent
electrophysiological study for clinical arrhythmias. Inter- and intraatrial conduction times were
measured from intracardiac electrograms. Atrial conduction times were also measured by tissue
Doppler echocardiography by evaluating atrial electromechanical delay between lateral mitral
annulus, septal mitral annulus, and right ventricular tricuspid annulus. The correlation between
electrophysiological and echocardiographic atrial conduction times were analyzed.
Results: We found a weak correlation between the measurements of interatrial conduction
times with the electrophysiological and tissue Doppler techniques (r = 0.308; p = 0.002). The
correlation for intraleft atrial conduction times was moderate (r = 0.652; p < 0.001). There
was no correlation between the measurements of intra-right atrial conduction times.
Conclusions: We concluded that tissue Doppler echocardiography can be used for the
measurement of interatrial and intra-left atrial conduction times. Tissue Doppler
echocardiography can be a suitable technique to evaluate atrial substrate. (Cardiol J 2012;
19, 5: 487-493
Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions
Background: The aim of this study was to assess the effect of trans-tricuspid placement of permanent pacemaker (PPM), implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) leads prospectively on tricuspid valve and right-sided heart functions using two-dimensional echocardiography.
Methods: A total of 41 patients (31 male, mean age: 63.6 ± 12.2 years) were included in this prospective study. Initial echocardiographic evaluation was performed before cardiac device implantation and re-evaluation by echocardiography was performed immediately after the procedure and at 1st, 6th and 12th months. In addition to standard echocardiographic examinations, vena contracta (VC), proximal isovelocity surface area (PISA), and tissue Doppler evaluations were also performed in the study population.
Results: Tricuspid regurgitation (TR) is worsened by 1 grade in 70.8% of the patients and 2 grades in 17.1% of the patients in the follow-up. Eight patients without baseline TR developed new-onset TR (9.8% mild, 9.8% moderate) after lead implantation. In the follow-up period, 41.5% of the patients who had mild TR before lead implantation developed moderate TR and 7.3% developed severe TR, whereas 19.5% of the patients with moderate TR developed severe TR during the follow-up. In the follow-up period, VC of TR was increased [median: 0.32 (0.16–0.60) cm in pre-implantation period, and 0.41 (0.18–0.80) cm at 12th month, p = 0.001]. Similarly PISA value of TR was also increased [median: 0.46 (0.15–1.10) cm in pre-implantation period and 0.52 (0.28–1.20) cm at 12th month, p = 0.001]. However, there is not a significant difference between PPMs/ICDs and CRTs regarding the effects on TR (p < 0.05). In addition, right ventricular dimensions and right atrial volumes were increased during the follow-up.
Conclusions: Implantation of permanent transvenous right ventricular electrode is associated with worsening of TR, right atrial and right ventricular dimensions. Further studies are needed in order to both outline the effect of those findings on outcomes and clarify the time dependent changes in those functions
The use of Amplatzer Vascular Plug® to treat coronary steal due to unligated thoracic side branch of left internal mammary artery: Four year follow-up results
Left internal mammary artery (LIMA) is the most commonly used graft during coronary
bypass surgery. LIMA side branches are clipped during surgery in order to prevent coronary
steal. In cases of patent LIMA side branches, there are differingapproaches. Herein, we report
a case with patent thoracic side branch of LIMA graft, occlusion of this side branch by
Amplatzer Vascular Plug because of documented myocardial ischemia, and long term
follow-up results. (Cardiol J 2012; 19, 2: 197–200
Baseline aortic pre-ejection interval predicts reverse remodeling and clinical improvement after cardiac resynchronization therapy
Background: Cardiac resynchronization therapy (CRT) has been shown to reduce heart
failure-related morbidity and mortality. However, approximately one in three patients do not
respond to CRT. The aim of the current study was to determine the parameter(s) which predict
reverse remodeling and clinical improvement after CRT.
Methods: A total of 54 patients (43 male, 11 female; mean age 61.9 ± 10.5 years) with heart
failure and New York Heart Association (NYHA) class III–IV symptoms and in whom left
ventricular ejection fraction (LVEF) was £ 35% and QRS duration was ≥ 120 ms, despite
optimal medical therapy, were enrolled. An echocardiographic examination was performed
before, and six months after, CRT. An echocardiographic response was defined as a reduction
of end-systolic volume ≥ 10% after six months, and a clinical response was defined as
a reduction ≥ 1 in the NYHA functional class score.
Results: An echocardiographic response was observed in 38 (70.4%) of the patients and
a clinical response occurred in 41 (75.9%) of the patients. Of the dyssynchrony parameters,
only the aortic pre-ejection interval (APEI) was observed to significantly predict the clinical
response (p = 0.048) and echocardiographic response (p = 0.037). A 180.5 ms cut-off value
for the APEI predicted the clinical response with a sensitivity of 92.3% and a specificity of
39%, and the echocardiographic response with a sensitivity of 93.0% and a specificity of 42%.
Conclusions: APEI derived from pulsed-wave Doppler, which is available in every echocardiography
machine, is a simple and practical method that could be used to select patients for CRT.
(Cardiol J 2011; 18, 6: 639–647
Total white blood cell count is associated with the presence, severity and extent of coronary atherosclerosis detected by dual-source multislice computed tomographic coronary angiography
Background: Total white blood cell (WBC) count has been consistently shown to be an
independent risk factor and predictor for future cardiovascular outcomes, regardless of disease
status in coronary artery disease (CAD). The purpose of this study is to evaluate the relationship
between total WBC count and the presence, severity and extent of coronary atherosclerosis
detected in subjects undergoing multislice computed tomographic (MSCT) coronary angiography
for suspected CAD.
Methods: A total of 817 patients were enrolled in this cross-sectional study. Non-significant
coronary plaque was defined as lesions causing £ 50% luminal narrowing, and significant
coronary plaque was defined as lesions causing > 50% luminal narrowing. For each segment,
coronary atherosclerotic lesions were categorized as none, calcified, non-calcified and mixed.
All images were interpreted immediately after scanning by an experienced radiologist.
Results: An association between hypertension, diabetes mellitus, age, gender, hyperlipidemia,
smoking, total WBC counts and coronary atherosclerosis was found when patients were
grouped into two categories according to the presence of coronary atherosclerosis (p < 0.05).
Although plaque morphology was not associated with total WBC counts, the extent of coronary
atherosclerosis was increased with higher total WBC quartiles (p = 0.006). Patients with
critical luminal stenosis had higher levels of total WBC counts when compared to patients with
non-critical luminal narrowing (7,982 ± 2,287 vs 7,184 ± 1,944, p < 0.05).
Conclusions: Our study demonstrated that total WBC counts play an important role in
inflammation and are associated with the presence, severity and extent of coronary atherosclerosis
detected by MSCT. Further studies are needed to assess the true impact of WBC counts
on coronary atherosclerosis, and to promote its use in predicting CAD. (Cardiol J 2011; 18, 4:
371–377
- …